NLS Pharmaceutics AG
NLSP
查看詳細走勢圖
0.762USD
0.000
收盤 12/24, 13:00（美東）報價延遲15分鐘
3.16M總市值
--本益比TTM
盤中分時
1分
30分
1小時
日k
週k
月k
日k
今天
0.00%
5天
0.00%
1月
0.00%
6月
-66.43%
今年開始到現在
-63.89%
1年
-59.76%
查看詳細走勢圖
TradingKey NLS Pharmaceutics AG股票評分
單位: USD 更新時間: 2025-10-27操作建議
當前估值低估，機構持股佔比非常高，近一個月多位分析師給出公司評級為。最高目標價max_target_price。目前股價在壓力位和支撐位之間，可以做區間波段操作。
NLS Pharmaceutics AG評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
0
分析師
--
評級
0.000
目標均價
0.00%
漲幅空間
數據免責聲明：分析師評級與目標價由LSEG提供，僅供參考，不應當作投資建議
NLS Pharmaceutics AG亮點
亮點風險
NewcelX AG, formerly NLS Pharmaceutics AG, is a Switzerland-based company primarily engaged in the biotechnology industry. The Company focuses on the discovery and development of therapies for rare and complex central nervous system (CNS) disorders, including sleep and neurodevelopmental conditions. The Company offers products like Quilience, which is a clinical-stage pharmaceutical compound. It aims to support the treatment of narcolepsy by modulating monoamine neurotransmission and orexin receptor activity. The Company also develops product like Nolazol, a treatment candidate for Attention Deficit Hyperactivity Disorder (ADHD). The Company is a publicly traded company, listing on the NASDAQ.
NLS Pharmaceutics AG新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
NLS Pharmaceutics AG簡介
NewcelX AG, formerly NLS Pharmaceutics AG, is a Switzerland-based company primarily engaged in the biotechnology industry. The Company focuses on the discovery and development of therapies for rare and complex central nervous system (CNS) disorders, including sleep and neurodevelopmental conditions. The Company offers products like Quilience, which is a clinical-stage pharmaceutical compound. It aims to support the treatment of narcolepsy by modulating monoamine neurotransmission and orexin receptor activity. The Company also develops product like Nolazol, a treatment candidate for Attention Deficit Hyperactivity Disorder (ADHD). The Company is a publicly traded company, listing on the NASDAQ.
公司代碼NLSP
公司NLS Pharmaceutics AG
CEOZwyer (Alexander)
網址https://nlspharma.com/
常見問題
NLS Pharmaceutics AG(NLSP)的當前股價是多少？
NLS Pharmaceutics AG(NLSP)的當前股價是 0.762。
NLS Pharmaceutics AG 的股票代碼是什麼？
NLS Pharmaceutics AG的股票代碼是NLSP。
NLS Pharmaceutics AG股票的52週最高點是多少？
NLS Pharmaceutics AG股票的52週最高點是4.740。
NLS Pharmaceutics AG股票的52週最低點是多少？
NLS Pharmaceutics AG股票的52週最低點是0.740。
NLS Pharmaceutics AG的市值是多少？
NLS Pharmaceutics AG的市值是3.16M。
NLS Pharmaceutics AG的淨利潤是多少？
NLS Pharmaceutics AG的淨利潤為-4.06M。
現在NLS Pharmaceutics AG(NLSP)的股票是買入、持有還是賣出？
根據分析師評級，NLS Pharmaceutics AG(NLSP)的總體評級為--，目標價格為--。
NLS Pharmaceutics AG(NLSP)股票的每股收益（EPS TTM）是多少
NLS Pharmaceutics AG(NLSP)股票的每股收益（EPS TTM）是-2.629。
相關品種
+0.41%
+0.94%
+0.51%
+0.34%
-0.17%
+1.42%
+0.75%
+1.80%
+0.38%
+0.66%
+0.08%
+0.82%
+0.81%
+0.08%
+0.23%
-0.05%
-0.19%
0.00%
+1.54%
+0.50%
